IBEX Ltd (IBEX)vsZepp Health Corp (ZEPP)
IBEX
IBEX Ltd
$27.75
-0.68%
TECHNOLOGY · Cap: $372.77M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
IBEX Ltd generates 133% more annual revenue ($603.27M vs $258.90M). IBEX leads profitability with a 7.3% profit margin vs -15.5%. IBEX earns a higher WallStSmart Score of 63/100 (C+).
IBEX
Buy63
out of 100
Grade: C+
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+85.5%
Fair Value
$208.36
Current Price
$27.75
$180.61 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 34 in profit
Safe zone — low bankruptcy risk
Reasonable price relative to book value
16.7% revenue growth
Earnings expanding 45.6% YoY
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
7.3% margin — thin
Negative free cash flow — burning cash
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : IBEX
The strongest argument for IBEX centers on P/E Ratio, Return on Equity, Altman Z-Score. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : IBEX
The primary concerns for IBEX are Market Cap, Profit Margin, Free Cash Flow.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
IBEX profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
IBEX scores higher overall (63/100 vs 41/100) and 16.7% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
IBEX Ltd
TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA
IBEX Limited provides comprehensive technology-enabled customer lifecycle experience solutions in the United States and internationally.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other INFORMATION TECHNOLOGY SERVICES Stocks
Want to dig deeper into these stocks?